Nicotinamide Adenine Dinucleotide Market Size is valued at 627.75 Million in 2024 and is predicted to reach 2149.59 Million by the year 2034 at a 13.02% CAGR during the forecast period for 2025-2034.
The crucial pyridine nucleotide nicotinamide adenine dinucleotide (NAD+) is required for several critical cellular processes, including DNA repair, epigenetically regulated gene expression, intracellular calcium signaling, and immunological functions. It also acts as an essential cofactor and substrate for these processes. One of the most well-known NAD supplements in contemporary biological research is NADH, a mitochondrial hormone that lengthens cells' life cycles (anti-aging).
The nicotinamide adenine dinucleotide market is primarily driven by increased customer demand for anti-aging products and growing knowledge of NAD's advantages in enhancing metabolism. Leading scientific investigations into the value of NAD for human health are encouraging product prospects. The nicotinamide adenine dinucleotide market is projected to expand due to rising pharmaceutical usage and demand.
Moreover, the product acceptance rate is also greatly influenced by ongoing R&D projects to enhance the impact of NADH or NAD+ on metabolism to provide therapeutic intervention in inflammatory illnesses. However, strict government dosage controls to prevent harmful health effects are expected to limit industry growth. The regulatory agencies of many countries have only designated NAD as OTC because the dosage and course of treatment impact how effective it is.
The nicotinamide adenine dinucleotide market is segmented on grade and application. Based on grade, the market is segmented into food, pharmaceutical, and others. Based on application, the nicotinamide adenine dinucleotide market is segmented into dietary supplements, pharmaceuticals, anti-aging products and others.
Based on grade, the market is segmented into food, pharmaceutical, and others. The food grade category grabbed the highest revenue share, and it is anticipated that it will continue to hold that position during the anticipated time. The usage of NAD in the food and beverage business has increased dramatically due to its antioxidant characteristics, which has increased demand for NAD of the food grade. The significant role of NAD as a substrate and cofactor for numerous essential biological processes, such as DNA repair and epigenetically controlled gene expression, is anticipated to propel the market further.
Based on application, the nicotinamide adenine dinucleotide market is segmented into dietary supplements, pharmaceuticals, anti-aging products and others. The pharmaceuticals category is anticipated to grow significantly over the forecast period. The demand for NAD among pharmaceutical producers is fueled by the popularity of NAD as an active component in the manufacturing process of numerous health medications. Due to the effectiveness of NAD-boosting drugs in repairing DNA damage and modifications to prevent diseases like Alzheimer's disease, dementia, and Parkinson's disease, there is expected to be a significant demand for NAD in the pharmaceutical industry by 2031, pushing the segment's revenue to over USD 135 million.
The North American nicotinamide adenine dinucleotide market is expected to register the highest market share in revenue soon. The presence of several NAD-based product manufacturing facilities and feed manufacturing firms are key factors influencing area industry statistics. Furthermore, the increased demand for NADH in North America results from the increasing prevalence of disorders brought on by an imbalance in the levels of NAD in the blood. Additionally, the Asia Pacific is anticipated to expand at a significant rate over the course of the forecast period. The consumer's increasing awareness of the health benefits is an important factor supporting the local market's growth. Additionally, the increased prevalence of cardiovascular illness in the area would spur demand for nicotinamide adenine dinucleotide (NAD), driving the development of the market for NAD.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 627.75 Million |
|
Revenue Forecast In 2034 |
USD 2149.59 Million |
|
Growth Rate CAGR |
CAGR of 13.02% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Grade, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Bontac Bioengineering, Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., F. Hoffmann-La Roche Ltd, HiMedia Laboratories, NutriScience Innovations, LLC, Nutrifoods, Bontac Bio-engineering(shenzhen)co., ltd, Krackeler Scientific, Shandong Lankang Bio-Technology Co., Ltd., OYC Americas, Inc., Xi'an Yinherb Bio-Tech Co., Ltd, Shenzhen Hygieia Biotechnology Co., Ltd, Zhejiang Dazhan Biotechnology Co., Ltd., Otto Chemie Pvt. Ltd., Uthever |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nicotinamide Adenine Dinucleotide Market Snapshot
Chapter 4. Global Nicotinamide Adenine Dinucleotide Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Grade Type Estimates & Trend Analysis
5.1. by Grade Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Grade Type:
5.2.1. Food Grade
5.2.2. Pharmaceutical Grade
5.2.3. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Dietary Supplements
6.2.2. Pharmaceuticals
6.2.3. Anti-aging Products
6.2.4. Others
Chapter 7. Nicotinamide Adenine Dinucleotide Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by Grade Type, 2021-2034
7.1.2. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.1.3. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.2.2. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.2.3. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.3.2. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.3.3. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.4.2. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.4.3. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.5.2. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.5.3. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Bontac Bioengineering
8.2.2. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
8.2.3. F. Hoffmann-La Roche Ltd
8.2.4. HiMedia Laboratories
8.2.5. NutriScience Innovations, LLC
8.2.6. Nutrifoods
8.2.7. Bontac Bio-engineering(shenzhen)co., ltd
8.2.8. Krackeler Scientific
8.2.9. Shandong Lankang Bio-Technology Co., Ltd.
8.2.10. OYC Americas, Inc.
8.2.11. Xi'an Yinherb Bio-Tech Co., Ltd
8.2.12. Shenzhen Hygieia Biotechnology Co., Ltd
8.2.13. Zhejiang Dazhan Biotechnology Co., Ltd.
8.2.14. Otto Chemie Pvt. Ltd.
8.2.15. Uthever
8.2.16. Other Prominent Players
By Grade-
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
